| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 09/22/1992 | CA1307646C Silicas |
| 09/17/1992 | WO1992015329A1 Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus |
| 09/17/1992 | WO1992015206A1 A pulverous composition, a method for preparing it, and a method for improving the taste of the composition |
| 09/16/1992 | EP0503425A1 Pellets containing sodium monofluorophosphate |
| 09/16/1992 | EP0502978A1 Synthesis, composition and medical application of cyclic pentaborate compounds |
| 09/15/1992 | US5147650 Fluid mixture of water, electrolytes, a sugar, glycerol and lactate |
| 09/15/1992 | CA1307523C Platium compounds suitable for use as pharmaceuticals |
| 09/15/1992 | CA1307467C Composition for the treatment of acne and seborrhea an hydroperoxide as active ingredient |
| 09/09/1992 | EP0502765A1 New dietary compositions based on phosphorylated lipid complexes and their use in sleeping disorders |
| 09/09/1992 | EP0292517B1 Improvements in or relating to the use of epidermal growth factor |
| 09/08/1992 | US5145686 Topical pharmaceutical compositions |
| 09/08/1992 | US5145668 Fluoride containing mouth rinses, dentifrices, and gels |
| 09/03/1992 | WO1992014484A1 Methods and compositions for the treatment of infection and control of flora |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500691A1 Stabilized stannous fluoride compositions for oral care. |
| 09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 09/02/1992 | CN1064014A Composite scabieticide (tines) and productive method thereof |
| 09/01/1992 | US5143732 Magnesium and iron salts which can be administered simultaneously, trace metal nutrients |
| 09/01/1992 | CA1306947C Antiseptic compositions |
| 09/01/1992 | CA1306945C Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 08/26/1992 | EP0500387A2 Methods and compositions for the treatment of infection and control of flora using haloperoxidase |
| 08/25/1992 | US5141955 Anti-inflammatory benzylselenobenzamides made from anilines and benzylamines |
| 08/25/1992 | CA1306693C Pharmaceutical compositions having antineoplastic activity |
| 08/25/1992 | CA1306684C Stabilisation of mercury-containing preservatives in ophthalmic medicaments |
| 08/25/1992 | CA1306682C Antitumor effect-enhancing agent for use in hyperthermia |
| 08/23/1992 | WO1992014452A1 Delayed release oral dosage forms for treatment of intestinal disorders |
| 08/20/1992 | WO1992013527A1 Water-dispersible tablets |
| 08/19/1992 | EP0498871A1 Antimicrobial preservation of plasma |
| 08/19/1992 | EP0315627B1 A method to treat blood |
| 08/18/1992 | US5139789 Mixture of sodium methanesulfonate, sodium bicarbonate, magnesium chloride, potassium chloride, potassium methanesulfonate and calcium chloride having controlled concentration of potassium and chloride ions |
| 08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 08/11/1992 | US5137722 Extract and pharmaceutical composition for treatment of calcium oxalate stone disease |
| 08/06/1992 | WO1992012716A1 Pharmaceutical composition containing granisetron and dexamethasone |
| 08/05/1992 | EP0497724A1 An agent for disintegrating gallstones |
| 08/04/1992 | US5135923 Inositol triphosphate |
| 07/29/1992 | EP0496546A1 Iodophor composition with increased stability |
| 07/29/1992 | EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole |
| 07/28/1992 | CA1305665C Macromolecular platinum antitumor compounds |
| 07/27/1992 | CA2059977A1 Agent for disintegrating gallstones |
| 07/23/1992 | WO1992011849A1 Swallowable pharmaceutical compositions |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/23/1992 | WO1992011773A1 Compositions and methods for achieving improved physiological response to exercice |
| 07/22/1992 | EP0495106A1 Osteogenesis promoter |
| 07/22/1992 | EP0494904A1 Device for oral administration of an active principle for preventive treatment of caries in babies. |
| 07/21/1992 | US5132323 Treatment of animals |
| 07/21/1992 | US5132119 Reducing scar tissue |
| 07/21/1992 | US5132118 Treatment of exercise-induced pulmonary hemorrhage in animals |
| 07/21/1992 | US5132113 Dietetics |
| 07/17/1992 | WO1992012720A1 Compound and pharmaceutical composition for treatment of calcium oxalate stone disease |
| 07/17/1992 | CA2100781A1 Compound and pharmaceutical composition for treatment of calcium oxalate stone disease |
| 07/16/1992 | DE4100782A1 Aq. ozone preparations for ozone therapy and microbicidal use - contain dissolved ozone and are prepd. by bubbling an oxygen@-ozone mixt. through aq. soln. |
| 07/15/1992 | EP0494512A2 Composition and method for preventing fluorosis |
| 07/15/1992 | EP0413792B1 Products containing a lithium salt and a tumour necrosis factor |
| 07/15/1992 | EP0378549B1 Pharmaceutical composition for preventing and treating bacterial or viral diseases |
| 07/14/1992 | US5130230 Blood substitute |
| 07/14/1992 | US5130146 Anticaries agents formed by mixing water soluble fluoride and cationic salts and precipitation |
| 07/14/1992 | US5130145 Pharmaceutical compositions with anit-cancer activity and method for the treatment of cancer |
| 07/14/1992 | US5130124 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide |
| 07/14/1992 | CA1305057C Calcium salts |
| 07/09/1992 | WO1992010995A1 Novel compositions |
| 07/09/1992 | CA2098730A1 Compositions |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/07/1992 | US5128332 Method of treating cardiovascular diseases using inositoltrisphosphate |
| 07/07/1992 | US5128152 Iron-containing compositions and method for treating cancer |
| 07/07/1992 | US5128141 Otorhinolaryngological disorders |
| 07/07/1992 | US5128140 Gastrointestinal disorders; salt of bismuth, organic acid and an H2 receptor blocking anti-secretory agent |
| 07/07/1992 | US5128136 Iodine as gelling agent |
| 07/07/1992 | US5128125 Dissolving polypyrrolidone in 2-pyrrolidone and heating; precipitation |
| 07/07/1992 | CA1304688C Fluid therapy with 1-lactate and/or pyruvate anions |
| 07/07/1992 | CA1304685C Pharmaceutical composition containing cimetidine |
| 07/01/1992 | EP0493362A2 Compositions and kits for the treatment of oral diseases |
| 07/01/1992 | EP0492183A1 Phenylalanine-free food base for infants and small children |
| 07/01/1992 | EP0308436B1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment |
| 07/01/1992 | EP0179858B1 Antacid composition |
| 06/30/1992 | US5126149 Tellurium tetrahalide for treament of autoimmune deficiency syndrome |
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |
| 06/30/1992 | US5126127 Stabilized PVP-I solutions |
| 06/25/1992 | WO1992010828A1 Folded sheet means |
| 06/25/1992 | WO1992010177A1 Pharmaceutical compositions |
| 06/24/1992 | EP0490920A1 Pharmaceutical preparation binding with gastric acid. |
| 06/23/1992 | US5124144 Polyethylene glycol, sodium sulfate, sodium bicarbonate, sodium and potassium chlorides, saccharin, flavoring, retains isotonicity good taste |
| 06/17/1992 | EP0490380A2 Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent |
| 06/17/1992 | EP0490307A2 Composition for bicarbonate dialysis and its use |
| 06/16/1992 | US5122533 Psoriasis treatment, applying substituted thiol compound and allantoin |
| 06/16/1992 | US5122370 Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2 |
| 06/16/1992 | US5122369 Nutrient composition for preventing hair loss |
| 06/16/1992 | US5122366 Antismoke mouth wash comprising silver nitrate and propylene glycol |
| 06/16/1992 | CA1303503C Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex |
| 06/16/1992 | CA1303498C Composition and method for treatment of copper deficiency |
| 06/16/1992 | CA1303497C Modification of plant extracts from zygophyllaceae |
| 06/12/1992 | CA2057336A1 Composition and method for preventing fluorosis |
| 06/11/1992 | WO1992009292A1 Improvements in chemical compounds |
| 06/11/1992 | WO1992009291A1 Treatment of topical infections |
| 06/11/1992 | WO1992009290A1 Treatment of exercise-induced pulmonary hemorrhage in animals |
| 06/11/1992 | WO1992009288A1 Foam-like pharmaceutical composition based on alginic acid |
| 06/11/1992 | WO1992002234A3 Reduction or prevention of sensitization to drugs |
| 06/11/1992 | CA2097334A1 Treatment of topical infections |
| 06/09/1992 | US5120545 Sensitizing drug and antigen processing-inhibiting agent |
| 06/09/1992 | US5120527 Paramagnetic oil emulsions as mri contrast agents |